This website uses cookies to ensure you get the best experience on our website.
Privacy Policy
I Agree
UroToday
Contact
Login
Sign Up Free
Transformative Evidence
mCRPC
PEACE-3 Trial
PROfound Trial
The RALU Study: Treatment Considerations in the First Line Setting of mCRPC
VISION Trial
mHSPC
ARANOTE Trial
ARASENS Trial
nmCRPC
ARAMIS Trial
nmCSPC
EMBARK Trial
PSMA PET Imaging
COBRA Trial
CONDOR Trial
OSPREY Trial
Bladder Cancer
ADSTILADRIN
ANKTIVA
Bladder Cancer Detection
CORE-001 Study
Centers of Excellence
Urologic Oncology
Left Group
Health Policy
Health Policy
Ruchika Talwar, MD
Bladder Cancer
Bladder Cancer
Ashish Kamat, MD
Advanced Bladder Cancer
Shilpa Gupta, MD
Trimodality Therapy
Leslie Ballas, MD
Kidney Cancer
Advanced Kidney Cancer
Pedro Barata, MD, MSc
Endourology
Endourology
Jaime Landman, MD
Prostate Cancer
Localized Prostate Cancer
Matthew R. Cooperberg, MD, MPH
Decipher Genomic Classifier
Imaging Center
Phillip Koo, MD
mHSPC
Neeraj Agarwal, FASCO, MD
nmCRPC
Zachary Klaassen, MD, MSc
mCRPC Treatment
A. Oliver Sartor, MD
PSMA-Targeted Therapy
Advanced Prostate Cancer
Zachary Klaassen, MD, MSc
Disparities: Social Determinants of Health
Disparities: Social Determinants of Health
Samuel L. Washington III, MD, MAS
Translational Prostate Cancer
Translational Science in Prostate Cancer
Andrea Miyahira, Ph.D
Women in Science
Andrea Miyahira, Ph.D
Upper Tract Urothelial Carcinoma
Upper Tract Urothelial Carcinoma
Sam S. Chang, MD, MBA
TESTICULAR, PENILE & RARE GU MALIGNANCIES
Testicular Cancer
Pelvic Health & Reconstruction
Bladder Health
Diane K. Newman, DNP, ANP-BC, FAAN
Pelvic Health
Diane K. Newman, DNP, ANP-BC, FAAN
Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU)
Stephen R. Kraus, MD
Urologic Catheters (Includes CAUTI)
Diane K. Newman, DNP, ANP-BC, FAAN
Videos
Exclusives
Conferences
Exclusive Collaborations
Independent Medical Education
Covid-19
The Prostate Cancer Foundation
Health Policy in Urological Diseases
Disparities: Social Determinants of Health
Practice Guidelines Reviews
Urologic Oncology
Prostate Cancer
Bladder Cancer
Kidney Cancer
Upper Tract Urothelial Tumors
Testicular Cancer
Endourology
Pelvic Health & Reconstruction
Pelvic Health & Reconstruction
Trials in Progress
Trials in Progress
Bladder Cancer
IMMORTAL
PIVOT-006
Kidney Cancer
RadiCal
SAMURAI
Middle Side
Prostate Cancer
ARAMON
ARASEC
ARASTEP
CLARIFY
ECLIPSE
ESCAPE
FORT
Right Side
Prostate Cancer
METANOVA
NRG-GU 0101
PROMISE
RTIRE
SECuRE
SHORTER
Clinical Trials
From the Editor
Search Clinical Trials
Articles
Urology (benign and malignant)
Urologic Oncology
Men's Health
Endourology & Stones
Pediatric Urology
COVID-19 and Genitourinary Cancers
Pelvic Health
Pelvic Health & Reconstruction
Conference Coverage
Recent Conferences
SCS AUA 2024
ASTRO 2024
IBCN 2024
ESMO 2024
BCAN TT 2024
All Conferences
View All
Quick Takes
ESMO 2024
PCF
UroToday Home
Newsletter Archive
GU Onc Daily
Go
Reset
Send Date
Subject
Created Date
ID
Asc
Desc
Reducing Bladder Cancer Recurrence: The Role of Improved Detection in Bladder Cancer
Sent on 30 November 2024
Receive via e-mail
Genomic Insights in Metastatic Hormone-Sensitive Prostate Cancer
Sent on 29 November 2024
Receive via e-mail
UroAlert - GU Oncology Daily
Sent on 29 November 2024
Receive via e-mail
UroAlert - GU Oncology Daily
Sent on 28 November 2024
Receive via e-mail
In Gratitude and Appreciation, A Message From UroToday!
Sent on 27 November 2024
Receive via e-mail
UroAlert - GU Oncology Daily
Sent on 27 November 2024
Receive via e-mail
New Horizons in the Treatment of Bladder Cancer
Sent on 26 November 2024
Receive via e-mail
UroAlert - GU Oncology Daily
Sent on 26 November 2024
Receive via e-mail
Leveraging Cutting-Edge Technologies to Enhance Prostate Cancer Treatments
Sent on 25 November 2024
Receive via e-mail
UroAlert - GU Oncology Daily
Sent on 25 November 2024
Receive via e-mail
Emerging Technologies to Advance Urologic Care in 2025 - LUGPA 2024 Annual Meeting Presentations
Sent on 23 November 2024
Receive via e-mail
Integrating New Technologies into Practice Management: LUGPA 2024 Annual Education
Sent on 22 November 2024
Receive via e-mail
UroAlert - GU Oncology Daily
Sent on 22 November 2024
Receive via e-mail
Precision Medicine at the Forefront of mCRPC Therapy
Sent on 21 November 2024
Receive via e-mail
UroAlert - GU Oncology Daily
Sent on 21 November 2024
Receive via e-mail
Innovative Therapies in GU Cancers
Sent on 20 November 2024
Receive via e-mail
UroAlert - GU Oncology Daily
Sent on 20 November 2024
Receive via e-mail
UroAlert - GU Oncology Daily
Sent on 19 November 2024
Receive via e-mail
Variant Histology Bladder Cancer Challenges and Future Directions
Sent on 18 November 2024
Receive via e-mail
UroAlert - GU Oncology Daily
Sent on 18 November 2024
Receive via e-mail
Advances in Staging and Personalized Radiation Therapy
Sent on 15 November 2024
Receive via e-mail
UroAlert - GU Oncology Daily
Sent on 15 November 2024
Receive via e-mail
Risk Assessment and Treatment Intensification in Advanced Prostate Cancer
Sent on 14 November 2024
Receive via e-mail
UroAlert - GU Oncology Daily
Sent on 14 November 2024
Receive via e-mail
Reducing Financial Burdens and Advancing Personalized Prostate Cancer Care for Veterans
Sent on 13 November 2024
Receive via e-mail
UroAlert - GU Oncology Daily
Sent on 13 November 2024
Receive via e-mail
Occupational and Environmental Risk Factors in Bladder Cancer
Sent on 12 November 2024
Receive via e-mail
UroAlert - GU Oncology Daily
Sent on 12 November 2024
Receive via e-mail
The Contemporary Role of Immunotherapy in Bladder Cancer
Sent on 11 November 2024
Receive via e-mail
UroAlert - GU Oncology Daily
Sent on 11 November 2024
Receive via e-mail
UroAlert - GU Oncology Daily
Sent on 08 November 2024
Receive via e-mail
Breakthrough Data in the Treatment of Advanced Prostate Cancer
Sent on 08 November 2024
Receive via e-mail
Bridging Evidence to Practice: Bladder Cancer Therapy Guidelines and Global Implementation
Sent on 07 November 2024
Receive via e-mail
UroAlert - GU Oncology Daily
Sent on 07 November 2024
Receive via e-mail
Targeted Treatment with Radioligand Therapy in Advanced Prostate Cancer
Sent on 06 November 2024
Receive via e-mail
UroAlert - GU Oncology Daily
Sent on 06 November 2024
Receive via e-mail
Advanced Prostate Cancer - Understanding Out-of-Pocket Medication Costs
Sent on 05 November 2024
Receive via e-mail
UroAlert - GU Oncology Daily
Sent on 05 November 2024
Receive via e-mail
Machine Learning Predicts Financial Toxicity in Stage IIA Non-Seminoma Treatments
Sent on 04 November 2024
Receive via e-mail
UroAlert - GU Oncology Daily
Sent on 04 November 2024
Receive via e-mail
BRAVO Trial Highlights Improved Detection Reduces Bladder Cancer Recurrence from South Central Section AUA
Sent on 02 November 2024
Receive via e-mail
South Central Section American Urological Association on Emerging Treatments for NMIBC and Ablative Treatments for Renal Cell Carcinoma
Sent on 01 November 2024
Receive via e-mail
UroAlert - GU Oncology Daily
Sent on 01 November 2024
Receive via e-mail
UroAlert - GU Oncology Daily
Sent on 31 October 2024
Receive via e-mail
South Central Section American Urological Association (AUA): Insights in Prostate Cancer Treatment
Sent on 31 October 2024
Receive via e-mail
UroAlert - GU Oncology Daily
Sent on 29 October 2024
Receive via e-mail
Bladder Preservation Strategies - A Modern Choice for Patients
Sent on 29 October 2024
Receive via e-mail
UroAlert - GU Oncology Daily
Sent on 28 October 2024
Receive via e-mail
UroAlert - GU Oncology Daily
Sent on 25 October 2024
Receive via e-mail
Strategies for Diagnosis and Treatment of Metastatic Prostate Cancer
Sent on 25 October 2024
Receive via e-mail
Page
of 100
Display #
5
10
15
20
25
30
50
100
Results 1 - 50 out of 4996
Send the selected Newsletters to...
Name
E-mail
Send
×
Login
Login to update email address, newsletter preferences and use bookmarks.
Email
Password
Login
Forgot Password?
Sign Up Free
